Hence, a wider range of immunohistochemical markers, including chromogranin and TTF-1 to support a diagnosis of small cell carcinoma, and CD99, vimentin, or FLI1 for PNET should be used for the differential diagnosis. The gene discussed is CD99; the disease is small cell carcinoma.